Conflicting data exists regarding the association of chemerin with inflammatory activity and fibrosis in NASH3,28, but in advanced stages NASH is associated with decreased hepatic chemerin expression and loss of functional parenchyma in severe liver cirrhosis might additionally contribute to reduced chemerin levels19. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatohepatitis.